XML 52 R31.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 30, 2023
Accounting Policies [Abstract]  
Schedule of Allowance for Doubtful Accounts
Activity related to our allowance for credit losses was as follows (in thousands):
Fiscal Year Ended
December 30, 2023December 31, 2022December 25, 2021
Balance at beginning of year$168 $195 $248 
Charges (reversals) to costs and expenses333 (27)(53)
Balance at end of year$501 $168 $195 
Schedules of Concentration of Risk, by Customer
The following customers represented 10% or more of our revenues:
Fiscal Year Ended
December 30, 2023December 31, 2022December 25, 2021
Intel Corporation17.1 %19.0 %20.4 %
Samsung Electronics Co., LTD.**11.4 %
* Less than 10% of revenues.
Schedule of Product Warranty Liability Reconciliation
A reconciliation of the changes in our warranty liability is as follows (in thousands):
 Fiscal Year Ended
 December 30, 2023December 31, 2022December 25, 2021
Balance at beginning of year$4,199 $2,805 $3,918 
Accruals7,771 7,746 5,759 
Settlements(8,687)(6,352)(6,872)
Reduction - FRT divestiture(106)— — 
Balance at end of year$3,177 $4,199 $2,805 
Schedule of Calculation of Numerator and Denominator in Earnings Per Share
The following table reconciles the shares used in calculating basic net income per share and diluted net income per share (in thousands):
 Fiscal Year Ended
 December 30, 2023December 31, 2022December 25, 2021
Weighted-average shares used in computing basic net income per share77,370 77,578 77,787 
Add potentially dilutive securities789 623 1,346 
Weighted-average shares used in computing basic and diluted net income per share78,159 78,201 79,133 
Schedule of Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive loss (“AOCL”) includes the following items, the impact of which has been excluded from earnings and reflected as components of stockholders' equity as shown below (in thousands):
December 30, 2023December 31, 2022
Unrealized losses on available-for-sale marketable securities and other investments$(727)$(2,749)
Translation adjustments(5,568)(5,675)
Unrealized gains on derivative instruments2,243 2,846 
Accumulated other comprehensive loss$(4,052)$(5,578)